What's new in multiple sclerosis treatment?

Multiple sclerosis (MS) is a chronic autoimmune disease that attacks the central nervous system, often leading to debilitating symptoms. Treatments for MS vary and include injections, oral medications, and infusions. During a relapse, patients are typically given high-dose corticosteroids via intravenous infusion to reduce inflammation and restore function quickly. These treatments often involve time-consuming and sometimes expensive hospital stays.

In England, individuals with MS will soon have access to a take-home pill to manage relapses, eliminating the need for hospital visits for injections or infusions. The pill is called Cladribine and is proving beneficial not only for those with severe MS but also for individuals with active relapsing-remitting MS, as it helps reduce the frequency and severity of relapses. For patients like Clare Elgar, who was diagnosed with MS in 2021, Cladribine offers newfound convenience. She shares, “Being able to take the treatment at home meant I could maintain my day-to-day routine and not have to travel to the hospital.”

While advancements like Cladribine offer new hope for managing MS relapses, ongoing support is crucial for those living with the disease. The Autoimmune Registry recently partnered with MS Focus, a nonprofit organization that provides free services that address the critical needs of people with MS and their families, helping them maintain the best quality of life. The organization's primary focus is on providing individuals with MS the help they need to maintain their health and well-being, continue to be productive and independent, and keep a roof over their heads and a safe environment in their homes.

To support the Autoimmune Registry, please share our information with others with autoimmune diseases. Donations are also greatly appreciated!